Task: Answer the multiple-choice question.
Question: Which compound exhibits a 1.998% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) COC(=O)c1ccc(N2C(=O)CC(SCCN)C2=O)cc1
(b) O=C(CSc1nnc(-c2ccc(C(F)(F)F)cn2)o1)Nc1cccc(Cl)c1
(c) Cc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1
(d) Cc1cc(C(=O)O)ccc1N/C=C1\CCCCC1=O
Answer: c. Cc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1
Cc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1
N-(4-methylphenyl)-2-(6-pyridin-2-ylpyridazin-3-yl)sulfanylacetamide